You have 9 free searches left this month | for more free features.

Leukotriene receptor agonist (LTRA)

Showing 1 - 25 of 8,262

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asthma Trial (BDA MDI, AS MDI)

Not yet recruiting
  • Asthma
  • BDA MDI
  • AS MDI
  • (no location specified)
Aug 15, 2022

Asthma Trial in Worldwide (MTPS9579A, Placebo)

Completed
  • Asthma
  • Bakersfield, California
  • +35 more
May 25, 2022

Asthma in Children Trial in Xi'an (Fluticasone propionate inhaled aerosol)

Not yet recruiting
  • Asthma in Children
  • Fluticasone propionate inhaled aerosol
  • Xi'an, Shanxi, China
    Department of Pediatrics, Xijing Hospital
Jun 29, 2021

Nephrotic Syndrome Trial in Multan (Montelukast)

Completed
  • Nephrotic Syndrome
  • Multan, PPunjab, Pakistan
    Department of Pediatric Nephrology, The Children's Hospital and
Mar 23, 2021

Status Asthmaticus Trial in Nashville (Montelukast Oral Granules, Albuterol, Corticosteroid)

Not yet recruiting
  • Status Asthmaticus
  • Montelukast Oral Granules
  • +2 more
  • Nashville, Tennessee
    Monroe Carell Jr. Children's Hospital at Vanderbilt
Apr 5, 2023

Moderate Covid19 Trial in Riyadh (Leukotriene Receptor Antagonist, Placebo)

Recruiting
  • Moderate Covid19
  • Leukotriene Receptor Antagonist
  • Placebo
  • Riyadh, Saudi Arabia
    King Abdulaziz Medical city, MNGHA
May 5, 2021

Allergic Rhinitis Due to Weed Pollen, Montelukast Trial in Beijing (Start taking Montelukast Sodium Tablets 10mg quaque die

Completed
  • Allergic Rhinitis Due to Weed Pollen
  • Montelukast
  • Start taking Montelukast Sodium Tablets 10mg quaque die orally two weeks before peak pollen count.
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Sep 1, 2021

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases Trial in Boston (Belumosudil, Fluticasone,

Not yet recruiting
  • Bronchiolitis Obliterans Syndrome
  • +3 more
  • Boston, Massachusetts
  • +3 more
Jun 27, 2023

Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)

Completed
  • Hair Diseases
  • +2 more
  • DA-OTC-002
  • Manaus, Brazil
    Hospital Oscar Nicolau
Oct 20, 2023

Pulmonary Arterial Hypertension Trial in Tempe (Prostacyclin Receptor Agonist)

Recruiting
  • Pulmonary Arterial Hypertension
  • Prostacyclin Receptor Agonist
  • Tempe, Arizona
    Celerion
Aug 16, 2022

Effects of GLP-1 Agonists on Gastric Volume

Not yet recruiting
  • Diabetes
  • +3 more
  • Gastric Ultrasound
  • Charleston, South Carolina
    Medical University of South Carolina
May 10, 2023

Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)

Not yet recruiting
  • Type 2 Diabetes
  • Diabetes Mellitus, Type 2
  • (no location specified)
Feb 6, 2023

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

    Recruiting
    • Seasonal Allergic Rhinitis
    • LP-003 dose 1
    • +2 more
    • Beijing, Beijing, China
    • +16 more
    Sep 18, 2023

    Metabolic-associated Fatty Liver Disease, Type 2 Diabetes Trial (Empagliflozin, Dulaglutide, Empagliflozin and Dulaglutide)

    Not yet recruiting
    • Metabolic-associated Fatty Liver Disease
    • Type 2 Diabetes
    • (no location specified)
    Oct 1, 2022

    PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese Trial (Semaglutide)

    Not yet recruiting
    • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
    • Obese
    • (no location specified)
    Apr 6, 2023

    Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

    Active, not recruiting
    • Breast Cancer
    • Aurora, Colorado
    • +23 more
    Jan 30, 2023

    Diabetes, Type 2 Trial in Amsterdam (device, drug, other)

    Recruiting
    • Diabetes Mellitus, Type 2
    • ReCET
    • +2 more
    • Amsterdam, North-Holland, Netherlands
      Amsterdam UMC
    Aug 9, 2023

    Healthy Trial in Merksem (Ponesimod, Carbamazepine)

    Recruiting
    • Healthy
    • Merksem, Belgium
      Clinical Pharmacology Unit
    Jan 31, 2023

    Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)

    Recruiting
    • Neuroendocrine Tumors
    • Gallium-68 NODAGA-JR11
    • Beijing, Beijing, China
    • +1 more
    Jul 27, 2022

    Acromegaly Trial in Worldwide (Paltusotine, Placebo)

    Recruiting
    • Acromegaly
    • Phoenix, Arizona
    • +67 more
    Aug 8, 2022

    Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

    Recruiting
    • Glaucoma, Suspect
    • Aberration, Corneal Wavefront
    • Low dosage selective alpha-2 receptor agonists topical eyedrop
    • High dosage selective alpha-2 receptor agonists topical eyedrop
    • Banhā, QA, Egypt
      Ahmed Abdelshafy
    Jan 2, 2023

    Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide

    Recruiting
    • Type 2 Diabetes
    • Obesity
    • Semaglutide 1.34 MG/ML [Ozempic]
    • +3 more
    • Hellerup, Capital Region, Denmark
      Center for Clinical Metabolic Research, Gentofte Hospital
    May 19, 2022